Conditions: Bacterial Pneumonia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 771
Healthy volunteers: no

Brief summary:
Study 0019 (NCT00124020) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Telavancin intervention 2: Vancomycin
Intervention descriptions: intervention 1: Telavancin 10 mg/kg/day IV for up to 21 days intervention 2: Vancomycin 1 Gm administered every 12 hrs IV for up to 21 days

Protocol document: